The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Open accessAbstract
Plasma xanthine oxidase (XO) activity was defined as a source of enhanced vascular superoxide (O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} ) and hydrogen peroxide (H 2 O 2 ) production in both sickle cell disease (SCD) patients and knockout-transgenic SCD mice. There was a significant increase in the plasma XO activity of SCD patients that was similarly reflected in the SCD mouse model. Western blot and enzymatic analysis of liver tissue from SCD mice revealed decreased XO content. Hematoxylin and eosin staining of liver tissue of knockout-transgenic SCD mice indicated extensive hepatocellular injury that was accompanied by increased plasma content of the liver enzyme alanine aminotransferase. Immunocytochemical and enzymatic analysis of XO in thoracic aorta and liver tissue of SCD mice showed increased vessel wall and decreased liver XO, with XO concentrated on and in vascular luminal cells. Steady-state rates of vascular O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} production, as indicated by coelenterazine chemiluminescence, were significantly increased, and nitric oxide ( ⋅ NO)-dependent vasorelaxation of aortic ring segments was severely impaired in SCD mice, implying oxidative inactivation of ⋅ NO. Pretreatment of aortic vessels with the superoxide dismutase mimetic manganese 5,10,15,20-tetrakis( N -ethylpyridinium-2-yl)porphyrin markedly decreased O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} levels and significantly restored acetylcholine-dependent relaxation, whereas catalase had no effect. These data reveal that episodes of intrahepatic hypoxia-reoxygenation associated with SCD can induce the release of XO into the circulation from the liver. This circulating XO can then bind avidly to vessel luminal cells and impair vascular function by creating an oxidative milieu and catalytically consuming ⋅ NO via O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} -dependent mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding of plasma XO to ECs can lead to vascular dysfunction (45, 71, 562, 612, 1010).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Self-citationRed Cell Metabolism: A Manual of Biochemical Methods.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-6-985_1 · Cited by 2,327
Radí, R., Beckman, J. S., Bush, K. M., & Freeman, B. Α. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,201
Self-citationRubbo, H., Radí, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., KIRK, M. C., & Freeman, B. Α. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47160-8 · Cited by 1,350
Self-citationFormation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
van der Vliet, A., Eiserich, J. P., Halliwell, B., & Cross, C. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7617 · Cited by 780
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
Superoxide and peroxynitrite inatherosclerosis.
White, C. R., Brock, T. A., Chang, L. Y., Crapo, J. D., BRISCOE, P. M., Ku, D. D., Bradley, W. A., Gianturco, S. H., Gore, J. Z., & Freeman, B. Α. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1044 · Cited by 684
Self-citationKissner, R., Nauser, T., Bugnon, P., Lye, P. G., & Koppenol, W. H. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970160x · Cited by 629
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., & Struthers, A. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.746 · Cited by 463
Spontaneous oxygen radical generation by sickle erythrocytes.
Hebbel, R. P., Eaton, J. W., Balasingam, M., & Steinberg, M. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110724 · Cited by 444
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
Kaul, D. K., & Hebbel, R. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9225 · Cited by 416
White, C. R., Darley-Usmar, V, Berrington, W. R., McAdams, M., Gore, J. Z., Thompson, J. A., Parks, D. A., Tarpey, M. M., & Freeman, B. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8745 · Cited by 367
Self-citationBelcher, J. D., Marker, P. H., Weber, J. P., Hebbel, R. P., & Vercellotti, G. M. (2000) · Blood · doi:10.1182/blood.v96.7.2451 · Cited by 365
Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues.
Engerson, T. D., McKelvey, T. G., Rhyne, D. B., Boggio, E. B., Snyder, S. J., & Jones, H. P. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112990 · Cited by 350
Occlusion of Large Cerebral Vessels in Sickle-Cell Anemia
STOCKMAN, J. A., Nigro, M. A., Mishkin, M. M., & Oski, F. A. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871703 · Cited by 333
Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals
Parks, D. A., & Granger, D. N. (1983) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1983.245.2.g285 · Cited by 322
Self-citationBelcher, J. D., Marker, P. H., Weber, J. P., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2451.h8002451_2451_2459 · Cited by 306
Knockout-Transgenic Mouse Model of Sickle Cell Disease
Ryan, T. M., Ciavatta, D. J., & Townes, T. M. (1997) · Science · doi:10.1126/science.278.5339.873 · Cited by 300
Self-citationVilla, L. M., Salas, E., Darley-Usmar, V. M., Radomski, M. W., & Moncada, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12383 · Cited by 291
Amaya, Y., Yamazaki, K., Sato, M., Noda, K., Nishino, T., & Nishino, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77283-9 · Cited by 275
Pegelow, C. H., Colangelo, L. H., Steinberg, M. H., Wright, E. C., Smith, J. A., Phillips, G., & Vichinsky, E. P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00407-x · Cited by 273
The species distribution of xanthine oxidase
Al-Khalidi, U. A. S., & Chaglassian, T. (1965) · Biochemical Journal · doi:10.1042/bj0970318 · Cited by 272
Binding of Xanthine Oxidase to Vascular Endothelium
Houston, M., Estévez, Á. G., Chumley, P. H., Aslan, M., Marklund, S. L., Parks, D. A., & Freeman, B. Α. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4985 · Cited by 271
Self-citationMetabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.
Kowaluk, E. A., Seth, P., & Fung, H. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10935-x · Cited by 253
Metalloporphyrin class of therapeutic catalytic antioxidants
Patel, M., & Day, B. J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01336-x · Cited by 253
Cardillo, C., Kilcoyne, C. M., Cannon, R. O., Quyyumi, A. A., & Panza, J. A. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.57 · Cited by 246
Reperfusion injury pathophysiology in sickle transgenic mice
Osarogiagbon, U. R., Choong, S., Belcher, J. D., Vercellotti, G. M., Paller, M. S., & Hebbel, R. P. (2000) · Blood · doi:10.1182/blood.v96.1.314 · Cited by 236
Tissue factor expression by endothelial cells in sickle cell anemia.
Solovey, A. N., Gui, L., Key, N. S., & Hebbel, R. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1932 · Cited by 221
Merkel, K. H., Ginsberg, P. L., Parker, J. C., & Post, M. J. (1978) · Stroke · doi:10.1161/01.str.9.1.45 · Cited by 216
Circulating xanthine oxidase: potential mediator of ischemic injury
Yokoyama, Y., Beckman, J. S., Beckman, T. K., Wheat, J. K., Cash, T., Freeman, B. Α., & Parks, D. A. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.258.4.g564 · Cited by 188
Self-citationSickle Cell Acute Chest Syndrome: Pathogenesis and Rationale for Treatment
Stuart, M. J., & Setty, Y. B. N. (1999) · Blood · doi:10.1182/blood.v94.5.1555.417k36_1555_1560 · Cited by 184
Prevalence of Priapism in Children and Adolescents With Sickle Cell Anemia
Mantadakis, E., Cavender, J. D., Rogers, Z. R., Ewalt, D. H., & Buchanan, G. R. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00013 · Cited by 181
Chemiluminescent Detection of Oxidants in Vascular Tissue
Tarpey, M. M., White, C. R., Suarez, E., Richardson, G. R., Radí, R., & Freeman, B. Α. (1999) · Circulation Research · doi:10.1161/01.res.84.10.1203 · Cited by 162
Self-citationRheologic predictors of the severity of the painful sickle cell crisis
Ballas, S., Larner, J. M., Smith, E. R., Surrey, S., Schwartz, E., & Rappaport, E. F. (1988) · Blood · doi:10.1182/blood.v72.4.1216.1216 · Cited by 158
Renal Abnormalities in Sickle Cell Disease
Allon, M. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390150015003 · Cited by 157
Juvenile Myelomonocytic Leukemia and Noonan Syndrome
Choong, K. L. M., Freedman, M. H., Chitayat, D. A., Kelly, E., Taylor, G. P., & Zipursky, A. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00014 · Cited by 150
Modulation of endothelial cell activation in sickle cell disease: a pilot study
Solovey, A., Solovey, A. N., Harkness, J., & Hebbel, R. P. (2001) · Blood · doi:10.1182/blood.v97.7.1937 · Cited by 148
Inhaled Nitric Oxide in Sickle Cell Disease with Acute Chest Syndrome
Atz, A. M., & WESSEL, D. L. (1997) · Anesthesiology · doi:10.1097/00000542-199710000-00037 · Cited by 142
Dupont, G. P., Huecksteadt, T. P., Marshall, B. C., Ryan, U. S., Michael, J. R., & Hoidal, J. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115563 · Cited by 136
Reactive Species in Sickle Cell Disease
ASLAN, M., THORNLEY‐BROWN, D., & FREEMAN, B. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06201.x · Cited by 136
Self-citationArginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease
Morris, C. R., Kuypers, F. A., Larkin, S. K., Sweeters, N., Simon, J., Vichinsky, E. P., & Styles, L. A. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02403.x · Cited by 126
Reactive Oxygen Species in Biological Systems
Gilbert, D. L., & Colton, C. A. (2002) · Springer eBooks · doi:10.1007/b113066 · Cited by 121
Radí, R., Rubbo, H., Bush, K., & Freeman, B. Α. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9844 · Cited by 120
Self-citationGlover, R. E., Ivy, E. D., Orringer, E. P., Maeda, H., & Mason, R. P. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1006 · Cited by 119
Shiu, Y.-T. E., Udden, M. M., & McIntire, L. V. (2000) · Blood · doi:10.1182/blood.v95.10.3232 · Cited by 117
Morris, C. R., Kuypers, F. A., Larkin, S. K., Sweeters, N., Simon, J., Vichinsky, E. P., & Styles, L. A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02403.x · Cited by 104
Arterial Blood Pressure in Adults With Sickle Cell Disease
Johnson, C. S. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340070071015 · Cited by 97
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease
Nath, K. A., Shah, V. H., Haggard, J. J., Croatt, A. J., Smith, L. A., Hebbel, R. P., & Katušić, Z. S. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.6.r1949 · Cited by 94
Plasma xanthine oxidase activity in patients with adult respiratory distress syndrome
Grum, C. M., Ragsdale, R. A., Ketai, L. H., & Simon, R. H. (1987) · Journal of Critical Care · doi:10.1016/0883-9441(87)90116-x · Cited by 94
Kuross, S., & Hebbel, R. (1988) · Blood · doi:10.1182/blood.v72.4.1278.1278 · Cited by 86
A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase
Kooij, A. (1994) · The Histochemical Journal · doi:10.1007/bf00174006 · Cited by 85
Physiologic Levels of Uric Acid Inhibit Xanthine Oxidase in Human Plasma
Tan, S., Radí, R., Gaudier, F. L., Evans, R. A., Rivera, A., Kirk, K. A., & Parks, D. A. (1993) · Pediatric Research · doi:10.1203/00006450-199309000-00013 · Cited by 83
Self-citationLande, W. M., Andrews, D., Clark, M., Braham, N., Black, D., Embury, S., & Mentzer, W. C. (1988) · Blood · doi:10.1182/blood.v72.6.2056.2056 · Cited by 78
Altered Vascular Reactivity in Sickle Hemoglobinopathy
Hatch, F. E., Crowe, L. R., Miles, D. E., Young, J., & Portner, M. E. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.1.2 · Cited by 69
The metabolites of nitric oxide in sickle‐cell disease
Rees, D. C., Cervi, P. L., Grimwade, D. J., O'Driscoll, A., Hamilton, M. S., Parker, N. E., & Porter, J. B. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05397.x · Cited by 69
Spasojević, I., Batinic̈‐Haberle, I., & Fridovich, I. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0303 · Cited by 68
Self-citationIn vivo blood flow abnormalities in the transgenic knockout sickle cell mouse
Embury, S. H., Mohandas, N., Pászty, C., Cooper, P. N., & Cheung, A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5977 · Cited by 51
Royall, J. A., Gwin, P. D., Parks, D. A., & Freeman, B. Α. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90742-f · Cited by 50
Self-citationKooij, A., Schijns, M., Frederiks, W. M., Noorden, C. J. F., & James, J. (1993) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899240 · Cited by 49
Serum xanthine oxidase in jaundice
GILER, S., Sperling, O., Brosh, S., Urca, I., & de Vries, À. (1975) · Clinica Chimica Acta · doi:10.1016/0009-8981(75)90375-7 · Cited by 40
Mohácsi, A., Kozlovszky, B., Kiss, I., Seres, I., & Fülöp, T. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00027-0 · Cited by 39
Paler-Martı́nez, A., Panus, P. C., Chumley, P. H., Ryan, U. S., Hardy, M. M., & Freeman, B. Α. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1211 · Cited by 32
Self-citationPotentiated adherence of sickle erythrocytes to endothelium infected by virus.
Hebbel, R. P., Visser, M. R., Goodman, J. L., Jacob, H., & Vercellotti, G. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113233 · Cited by 32
Uric Acid, Xanthine Oxidase and Other Risk Factors of Hypertension in Normotensive Subjects
Newaz, M., Adeeb, N. N. N., Muslim, N., Razak, T. A., & Htut, N. N. (1996) · Clinical and Experimental Hypertension · doi:10.3109/10641969609081033 · Cited by 30
THE LEUCOCYTE CURVE AS AN INDEX OF THE INFECTION IN RHEUMATIC FEVER 1
Swift, H. F., Miller, C., & Boots, R. H. (1924) · Journal of Clinical Investigation · doi:10.1172/jci100011 · Cited by 18
Shiu, Y.-T. E., Udden, M. M., & McIntire, L. V. (2000) · Blood · doi:10.1182/blood.v95.10.3232.010k16_3232_3241 · Cited by 18
Multiple organ dysfunction syndrome: Role of xanthine oxidase and nitric oxide
Parks, D. A., Skinner, K. A., Skinner, H. B., & Tan, S. (1998) · Pathophysiology · doi:10.1016/s0928-4680(98)00008-x · Cited by 13
Self-citationDiagnostic value of determination of serum xanthine oxidase activity in acute viral hepatitis.
Wolko, K., & Krawczyński, J. (1975) · PubMed · Cited by 6
Proceedings: Serum xanthine oxidase in hepatocellular damage.
GILER, S., Sperling, O., Brosh, S., Urca, I., & VRIES, A. D. (1975) · PubMed · Cited by 3
Research works printed but not linked: 8
- 10.1182/blood.V94.5.1555 · DOI
- C O Enwonwu Med Sci Res 17, 997–998 (1989).
- C R Morris, F A Kuypers, S Larkin, N Sweeters, J Simon, E P Vichinsky, L A Styles Br J Haematol 111, 498–500 (2000).
- S Giler, O Sperling, S Brosh, I Urca, A De Vries Isr J Med Sci 11, 1225 (1975).
- K Wolko, J Krawczynski Mater Med Pol 6, 95–98 (1974).
- D A Parks, D N Granger Am J Physiol 245, G285–G289 (1983).
- Y Yokoyama, J S Beckman, T K Beckman, J K Wheat, T G Cash, B A Freeman, D A Parks Am J Physiol 258, G564–G570 (1990).
- E A Kowaluk, P Seth, H L Fung J Pharmacol Exp Ther 262, 916–922 (1992).
Cited by
Sorted by citations
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Self-citationPulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,467
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationPacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Metadata
- Authors
- Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., Batinic-Haberle, I., White, C. R., & Freeman, B. A.
- Affiliations
- National Institutes of Health (US)
- Departments of Anesthesiology, Biochemistry and Molecular Genetics, Pathology, Medicine, and Surgery, Center for Free Radical Biology, Imaging Facility and Comprehensive Sickle Cell Disease Center, University of Alabama, Birmingham, AL 35233; Critical Care Medicine Department of the Warren G. Magnuson Clinical Center, and Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; and Department of...
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 98
- Issue
- 26
- Pages
- 15215-15220
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC65009
- OpenAlex
- W2014093734
- Cited by
- 391
- References
- 67
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 14 · 2019: 18 · 2018: 15 · 2017: 14 · 2016: 9 · 2015: 17 · 2014: 17 · 2013: 16 · 2012: 11
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p60hl058418-05)
- National Heart, Lung, and Blood Institute (R01HL64937, R01HL064937, P6-HL-58418, R01HL058115, R01-HL-58115)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- sickle cell disease, xanthine oxidase, superoxide, nitric oxide, hydrogen peroxide, hepatocyte injury, aorta, superoxide dismutase mimetic, manganese porphyrin
- MeSH terms
- Alanine Transaminase, Anemia, Sickle Cell, Animals, Endothelium, Vascular, Erythrocytes, Humans, Muscle Relaxation, Nitric Oxide, Superoxides, Xanthine Oxidase, Mice, Knockout, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review